Symbol: |
CASC5
|
Description: |
cancer susceptibility candidate 5 [Source:HGNC Symbol;Acc:24054]
|
Location: |
Chr15:40886218-40956540[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:213
Gene |
Compound |
Gen_sig |
Exp_pattern |
CASC5 |
6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- |
0.032 |
Down |
CASC5 |
NSC 117198 |
0.023 |
Down |
CASC5 |
NSC 119915 |
0.04 |
Down |
CASC5 |
VERNOLIDE |
0.032 |
Down |
CASC5 |
Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- |
0.039 |
Up |
CASC5 |
NSC 128166 |
0.034 |
Up |
CASC5 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.047 |
Down |
CASC5 |
NSC 13477 |
0.005 |
Up |
CASC5 |
EUPACUNIN |
0.02 |
Down |
CASC5 |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.046 |
Down |
CASC5 |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.036 |
Down |
CASC5 |
NSC 201902 |
0.041 |
Down |
CASC5 |
1,8-Octanediamine, N,N'-di-9-acridinyl- |
0.02 |
Down |
CASC5 |
1-Piperidineethanol, .alpha.-[p-(p-chlorostyryl)phenyl]- |
0.009 |
Up |
CASC5 |
NANAOMYCIN |
0.045 |
Down |
Expression pattern: Sensitivity / Resistance
Total:15 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:6
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:24
Total:2 Current:1
[First] [Prev]  Next Last 
|